GSE252944 AKT inhibition 10 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE252944_AKT inhibition_10_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE252944_AKT inhibition_10_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE252944_AKT inhibition_10_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE252944_AKT inhibition_10_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

long intergenic non-protein coding RNA 665

Gene

long intergenic non-protein coding RNA 662

Gene

MIR1915 host gene

Gene

SBDS pseudogene 1

Gene

ABCF2-H2BK1 readthrough

Gene

deleted in lymphocytic leukemia 2

Gene

long intergenic non-protein coding RNA 2984

Gene

IGFL2 antisense RNA 1

  • Gene

    DExD-box helicase 52


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    long intergenic non-protein coding RNA 662



  • Gene

    SBDS pseudogene 1


  • Gene

    ABCF2-H2BK1 readthrough


  • Gene

    deleted in lymphocytic leukemia 2


  • Gene

    long intergenic non-protein coding RNA 2984


  • Gene

    IGFL2 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.